Login / Signup

Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate® ) and BAY 81-8973 (Kovaltry® ) in patients with severe or moderate haemophilia A in prophylaxis.

Juan Eduardo Megías-VericatSantiago BonanadSaturnino HayaAna Rosa CidMaría Remedios MarquésEmilio Monte-BoquetSofía Pérez-AlendaPau BoschFelipe QuerolJosé Luis Poveda
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2019)
Keyphrases
  • cross sectional
  • high intensity
  • early onset
  • cell free
  • drug induced